Enhancing the Efforts of Advocacy Organizations

We work with partners globally to strengthen advocacy around disease prevention.
This week is "UN Week" which marks the annual United Nations General Assembly meeting in New York. Top leaders from around the world have descended upon NY to discuss many pressing issues on the global agenda, including the SDG goals and improving health worldwide.
With an estimated 37 million people currently living with HIV globally and 2.1 million people becoming newly infected each year, Johnson & Johnson stands united with the global community to fight HIV and care for those infected, and impacted.
Johnson & Johnson leadership reflects on how the company is helping to realize the goal of ending AIDS by 2030 through innovation partnerships and R&D efforts, and the work still to be done.
Learn how Johnson & Johnson is building on a 25-year legacy of commitment to end HIV through innovative partnerships and investments.
Integrated solutions focused on prevention, education and medicine are key to helping win the fight against AIDS.
In this Huffington Post blog, USAID Ambassador Deborah L. Birx, M.D., discusses how the DREAMS partnership aims to help combat HIV in adolescent girls and young women.
Johnson & Johnson issued a call for innovative ideas to reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries as part of the DREAMS Innovation Challenge, supported by PEPFAR.
Ending AIDS would be one of the greatest accomplishments in human history. Share your innovative solution through DREAMS.
Learn more about a three-day medical education workshop in Haiti to advance knowledge amongst local healthcare providers on the challenges and opportunities in pediatric HIV.
Johnson & Johnson honors the life and legacy of Nelson Mandela, reflecting on his commitment to raising HIV awareness in South Africa.
Three minutes is long enough for lives to change. Through unique partnerships, such as Helping Babies Breathe, Johnson & Johnson is helping to save the lives of newborns worldwide.
mothers2mothers connects mentor mothers with women in communities who are living with HIV to empower them to keep themselves and their babies healthy.
Johnson & Johnson announced a global partnership with Save the Children to support its core mission to improve newborn survival.
Additional support and funding is needed to help fight TB worldwide. Read more in this Health Affairs blog from Friends of the Global Fight Against AIDS, Tuberculosis and Malaria.
Learn how Johnson & Johnson employees “Unite to End TB” and bring new hope to those suffering from tuberculosis in Vietnam, South Africa and India.
World Economic Forum, Davos, SwitzerlandAddressing the emergence of superbugs and drug-resistant bacteria is critical to our economic future and global health.
Johnson & Johnson announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance, an industry-wide call to action that outlines how industry and governments can work together to support sustained innovation to address this growing problem.
Bloomberg reports on the industry-wide partnership to accelerate the development of drugs and diagnostics to help fight antimicrobial resistance.
Janssen and USAID entered into a new Memorandum of Understanding, as part of the U.S Government’s National Action Plan for combatting multi-drug resistant tuberculosis (MDR-TB), agreeing to expand patient access to novel MDR-TB therapies and increase funding for program partners.
Johnson & Johnson leadership reflects on a trip to South Africa where they met Chandre Heaton, a young woman who overcame XDR-TB.
Janssen leaders urged consideration of a special framework for innovation in antibiotics research and development at a congressional hearing.
Johnson & Johnson Vice President of Innovation, Global Public Health and Science Policy Communication, Seema Kumar shares her key highlights from the Global Fund Replenishment Conference to Fight HIV, Tuberculosis and Malaria.
Johnson & Johnson partnered with social action platform Global Citizen to elevate the global importance of strong public health programs.
Mental Health Now, or mhNOW, a new initiative founded by Global Development Incubator, Johnson & Johnson, Grand Challenges Canada, BasicNeeds, and StrongMinds, will help identify mental health solutions on a global scale.
Johnson & Johnson leaders discuss how public-private partnerships will help address global health crises.
Learn more about key themes related to global public health and STEM education that emerged at the 2016 World Economic Forum in Davos, Switzerland.
Johnson & Johnson committed $25 million, including product donations, to Operation Smile to help support their surgical missions.
Learn how we have joined public and private partners in the largest coordinated action to control or eliminate 10 neglected tropical diseases by 2020.
Learn more about Johnson & Johnson’s perspective on global collaboration to control or eliminate 10 neglected tropical diseases by 2020.
Learn about Johnson & Johnson’s commitment to improve the health of women and children in five key areas.

More From Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.